119 related articles for article (PubMed ID: 10586240)
1. The anatomy and cell biology of peripheral myelin protein-22.
Snipes GJ; Orfali W; Fraser A; Dickson K; Colby J
Ann N Y Acad Sci; 1999 Sep; 883():143-51. PubMed ID: 10586240
[TBL] [Abstract][Full Text] [Related]
2. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
Müller HW
Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
[TBL] [Abstract][Full Text] [Related]
3. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
4. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
Zielasek J; Toyka KV
Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256
[TBL] [Abstract][Full Text] [Related]
5. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
6. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
7. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
Adlkofer K; Naef R; Suter U
J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models of CMT1A and HNPP.
Suter U; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():247-53. PubMed ID: 10586249
[TBL] [Abstract][Full Text] [Related]
9. Trembler as a mouse model of CMT1A?
Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C
Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251
[TBL] [Abstract][Full Text] [Related]
10. Peripheral myelin protein 22: facts and hypotheses.
Suter U; Snipes GJ
J Neurosci Res; 1995 Feb; 40(2):145-51. PubMed ID: 7745607
[TBL] [Abstract][Full Text] [Related]
11. The Anatomy and Cell Biology of Peripheral Myelin Protein-22.
Snipes GJ; Orfali W; Fraser A; Dickson K; Colby J
Ann N Y Acad Sci; 1999 Oct; 883(1):143-151. PubMed ID: 29086928
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural immunocytochemical abnormalities of peripheral myelin proteins in hereditary sensory-motor neuropathies: 12 cases.
Anani T; Sindou P; Richard L; Diot M; Vallat JM
Ann N Y Acad Sci; 1999 Sep; 883():186-95. PubMed ID: 10586244
[TBL] [Abstract][Full Text] [Related]
15. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
16. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
[TBL] [Abstract][Full Text] [Related]
17. De novo Ser72Leu mutation in the peripheral myelin protein 22 in two Polish patients with a severe form of Charcot-Marie-Tooth disease.
Kochański A; Kabzińska D
Acta Biochim Pol; 2004; 51(4):1047-50. PubMed ID: 15625576
[TBL] [Abstract][Full Text] [Related]
18. Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?
Meekins GD; Emery MJ; Weiss MD
J Peripher Nerv Syst; 2004 Sep; 9(3):177-82. PubMed ID: 15363066
[TBL] [Abstract][Full Text] [Related]
19. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene.
Gabreëls-Festen A; Wetering RV
Ann N Y Acad Sci; 1999 Sep; 883():336-43. PubMed ID: 10586258
[TBL] [Abstract][Full Text] [Related]
20. Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage.
Nattkämper H; Halfter H; Khazaei MR; Lohmann T; Gess B; Eisenacher M; Willscher E; Young P
J Neurochem; 2009 Aug; 110(3):935-46. PubMed ID: 19493167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]